26 results
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
16 Apr 24
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
4:20pm
, offset by the upfront partnership payment received from Simcere. Based on its current operating plans, management
believes the Company has sufficient
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
designated by the recipient of the Award, free of any tax, deduction or offset; and any costs, fees or taxes incident to enforcing the Award shall
6-K
CNTB
Connect Biopharma Holdings Ltd
12 Sep 23
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
4:47pm
of RMB 211.5 million (USD 29.3 million), offset by adjustments of RMB 7.9 million (USD 1.1 million) and negative working capital change in our operating … -current assets of RMB 3.6 million (USD 0.5 million) due to deductible value-added tax ("VAT") which can offset against future VAT payables, a decrease
6-K
EX-99.1
8onndmoocud0w0l65k
23 Jun 23
House Lease Contract
4:31pm
6-K
h9v5 n156gn6fu0ai
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
F-3/A
e7ugv jex6rb
17 Jun 22
Shelf registration (foreign) (amended)
5:19pm
F-3/A
sdpbrs nmdcij
20 May 22
Shelf registration (foreign) (amended)
6:54pm
F-3
9rivepe trus
15 Apr 22
Shelf registration (foreign)
5:27pm
20-F
sxfm4lcc5r
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.13
qj37jksnpucagg4wt
31 Mar 22
Annual report (foreign)
4:33pm
6-K
EX-99.2
5s1eup39wk9gg45p
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
6-K
EX-99.2
38q 9zr59
3 Jun 21
Development program exploring the potential of CBP-174 in the treatment of chronic inflammatory pruritus
6:04am
424B4
vowy8m5z ueup0
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
rw5t07pa99vr 8eaqd7
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
EX-10.3
00jlohbl50n9v6ad3gb
17 Mar 21
Registration statement (foreign) (amended)
6:38am
F-1/A
gjw5cc0ftitxu
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-10.3
fjslgk7i22qe332n0prn
12 Mar 21
Registration statement (foreign) (amended)
5:02pm